^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    aspirin

    Associations

    News

    Trials
    Company:
    Generic mfg.
    Drug class:
    COX inhibitor
    Related drugs:
    Associations

    News

    Trials
    1d
    A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants (clinicaltrials.gov)
    P1, N=16, Recruiting, Bayer
    New P1 trial
    |
    aspirin
    4d
    ASPIK French: Study on Aspirin Versus Placebo in Resected Colon Cancer With PI3K Mutation Stage III or II High Risk (clinicaltrials.gov)
    P3, N=264, Active, not recruiting, University Hospital, Rouen | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    PI3K (Phosphoinositide 3-kinases)
    |
    aspirin
    7d
    CHASAP: Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy (clinicaltrials.gov)
    P3, N=500, Recruiting, Centre Hospitalier Intercommunal Creteil | Trial primary completion date: Feb 2026 --> Feb 2029
    Trial primary completion date
    |
    aspirin
    8d
    A real-world analysis of polycythemia vera at two comprehensive cancer centers in Cali, Colombia. (PubMed, Blood Cells Mol Dis)
    This study provides one of the first extensive characterizations of PV in southern Colombia, confirming internationally recognized clinical features, including advanced age at diagnosis, increased prevalence of cardiovascular comorbidities, and a predominance of high-risk classification. The low rate of finding JAK2 mutations suggests that molecular testing may not be as easy to get as it could be. Even if the treatment followed the guidelines, the risk of recurrence and thrombosis remained, showing that PV is a long-term and worsening condition. These findings highlight the urgent need to expand access to molecular diagnostics, develop tailored risk-adapted medicines, and initiate prospective multicenter studies in Latin America to optimize outcomes and quality of life in PV.
    Journal • Real-world evidence
    |
    JAK2 (Janus kinase 2)
    |
    Jakafi (ruxolitinib) • hydroxyurea • aspirin
    9d
    AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE (clinicaltrials.gov)
    P4, N=60, Recruiting, University Hospital, Bordeaux | Trial completion date: May 2024 --> May 2027 | Trial primary completion date: May 2024 --> May 2027
    Trial completion date • Trial primary completion date
    |
    aspirin
    10d
    ACASA-TAVI: AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation (clinicaltrials.gov)
    P3, N=360, Completed, Oslo University Hospital | Recruiting --> Completed | Trial completion date: Nov 2026 --> Jun 2026 | Trial primary completion date: Nov 2026 --> Jun 2026
    Trial completion • Trial completion date • Trial primary completion date
    |
    aspirin
    14d
    SPICAF: Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation (clinicaltrials.gov)
    P4, N=1148, Recruiting, Assistance Publique - Hôpitaux de Paris | Not yet recruiting --> Recruiting | Trial completion date: Mar 2028 --> Dec 2028 | Trial primary completion date: Sep 2025 --> Dec 2028
    Enrollment open • Trial completion date • Trial primary completion date
    |
    aspirin
    14d
    Personalized pharmacotherapy of colorectal cancer (PubMed, Inn Med (Heidelb))
    Colorectal cancer treatment is increasingly evolving into a precision oncology approach. Integration of molecular biomarkers enables tailored therapy decisions and opens new options, particularly in adjuvant and metastatic settings.
    Review • Journal • MSi-H Biomarker • IO biomarker
    |
    HER-2 (Human epidermal growth factor receptor 2) • BRAF (B-raf proto-oncogene) • MSI (Microsatellite instability)
    |
    BRAF V600E • MSI-H/dMMR • BRAF V600
    |
    aspirin
    17d
    To Compare the Pharmacodynamic and Short-term Clinical Effects of Standard DAPT, DAPT With Half-dose Ticagrelor, and Aspirin-free Half-dose Ticagrelor Monotherapy From the Day of PCI in Chronic Coronary Syndrome (CCS) (clinicaltrials.gov)
    P4, N=60, Completed, Kaohsiung Veterans General Hospital.
    New P4 trial
    |
    aspirin
    17d
    SMA-TB: Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis (clinicaltrials.gov)
    P2, N=426, Terminated, Fundació Institut Germans Trias i Pujol | Recruiting --> Terminated; The impact of the COVID-19 pandemic on TB diagnosis affected greatly the recruitment rate and posed challenges to the trial's timeline, consuming the funding needed to continue the enrolment.
    Trial termination
    |
    aspirin
    18d
    PROMISE: Pro-urokinase for Extended-Window Posterior Circulation Stroke (clinicaltrials.gov)
    P3, N=586, Not yet recruiting, The First Affiliated Hospital of Zhengzhou University
    New P3 trial
    |
    aspirin
    21d
    Clinician Notification to Increase Aspirin Prophylaxis for Preeclampsia Prevention (clinicaltrials.gov)
    P=N/A, N=1000, Not yet recruiting, Massachusetts General Hospital
    New trial
    |
    aspirin